Massive Thrombosis of Mitral Bioprosthesis Due to SARS-CoV-2 Infection

Thromboembolic events have been reported as frequent and fearsome complications in patients affected by SARS-CoV-2 infection. Patients undergoing cardiac valve replacement exhibit an increased risk of valve thrombosis, even with prosthetic biological valves, and especially in the first period after...

Descripción completa

Detalles Bibliográficos
Autores principales: Librera, Mariateresa, Paolillo, Stefania, Carlomagno, Guido, Santise, Gianluca, Mariniello, Antonio, Nardella, Saverio, Briguori, Carlo, Maselli, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505639/
https://www.ncbi.nlm.nih.gov/pubmed/36142921
http://dx.doi.org/10.3390/jcm11185277
Descripción
Sumario:Thromboembolic events have been reported as frequent and fearsome complications in patients affected by SARS-CoV-2 infection. Patients undergoing cardiac valve replacement exhibit an increased risk of valve thrombosis, even with prosthetic biological valves, and especially in the first period after surgery. The management of these patients is challenging and requires prompt interventions. We report the case of a young woman infected by SARS-CoV-2 three months after double cardiac valve replacement that developed a massive prosthetic biological valve thrombosis despite optimal anticoagulant therapy.

Ejemplares similares